LBIO (Longevity Biomedical) Dividend Payout Ratio: 0.00 (As of . 20)


What is Longevity Biomedical Dividend Payout Ratio?

Longevity Biomedical LBIO Dividend Payout Ratio is 0.00 as of . 20.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Longevity Biomedical's Dividend Payout Ratio for the months ended in . 20 was 0.00.

The historical rank and industry rank for Longevity Biomedical's Dividend Payout Ratio or its related term are showing as below:


LBIO's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-07-07), the Dividend Yield % of Longevity Biomedical is 0.00%.

Longevity Biomedical's Dividends per Share for the months ended in . 20 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Longevity Biomedical (NAS:LBIO) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Longevity Biomedical Dividend Payout Ratio Related Terms

Longevity Biomedical Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Dividend Payout Ratio Chart

Longevity Biomedical Annual Data
Trend
Dividend Payout Ratio

Longevity Biomedical Semi-Annual Data
Dividend Payout Ratio

LBIO vs : Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Longevity Biomedical's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Dividend Payout Ratio falls into.


Longevity Biomedical Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Longevity Biomedical's Dividend Payout Ratio for the fiscal year that ended in . 20 is calculated as

Dividend Payout Ratio=Dividends per Share (A: . 20 )/ EPS without NRI (A: . 20 )
=/
=N/A

Longevity Biomedical's Dividend Payout Ratio for the quarter that ended in . 20 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: . 20 )/ EPS without NRI (Q: . 20 )
=/
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Longevity Biomedical (LBIO) has a Dividend Payout Ratio of 0.00 as of . 20. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's Dividend Payout Ratio too high?
Longevity Biomedical's current Dividend Payout Ratio is 0.00.
How does Longevity Biomedical's Dividend Payout Ratio compare to ?
Longevity Biomedical's Dividend Payout Ratio of 0.00 can be compared against companies in the Biotechnology industry. The industry median Dividend Payout Ratio is 0.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Longevity Biomedical and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Biomedical's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Dividend Payout Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.